Postoperative Troponin in Children With Congenital Heart Disease | NCT01616394 | Trialant
CompletedObservationalUpdated Nov 19, 2014
Postoperative Troponin in Children With Congenital Heart Disease
ClinicalTrials.gov ID
NCT01616394
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
180Actual
Last Update Posted
Nov 19, 2014Estimated
Start Date
Feb 2012
Primary Completion Date
Oct 2014Actual
Completion Date
Oct 2014Actual
Brief Summary
The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.
Congenital Heart Disease
No interventions
There are no interventions for this study.
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery
Exclusion Criteria:
parental refusal
children older than 10 years
Observational Model
Cohort
Time Perspective
Prospective
No central contacts
There are no central contacts for this study.
Cliniques Universitaires saint Luc
Brussels, 1200, Belgium
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER